Home/Filings/4/0001179110-18-001884
4//SEC Filing

Cunnane Deirdre A. 4

Accession 0001179110-18-001884

CIK 0001454789other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:02 PM ET

Size

5.5 KB

Accession

0001179110-18-001884

Insider Transaction Report

Form 4
Period: 2018-02-08
Cunnane Deirdre A.
SVP, General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-08+100,000100,000 total
    Exercise: $1.28Exp: 2028-02-07Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2018 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 8, 2018 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.

Issuer

CATABASIS PHARMACEUTICALS INC

CIK 0001454789

Entity typeother

Related Parties

1
  • filerCIK 0001666942

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:02 PM ET
Size
5.5 KB